{"id":{"repo_id":"marshall","oai_identifier":"oai:mds.marshall.edu:etd-3002"},"canonical_url":"https://search.ndltd.org/etd/marshall/oai:mds.marshall.edu:etd-3002","repository":{"repo_id":"marshall","name":"Marshall University","base_url":"https://mds.marshall.edu/do/oai/"},"display":{"title":"Evaluation of disulfiram and derivatives as antimicrobial adjuvants","abstract":"Disulfiram (Antabuse) is an oral drug used for the treatment of alcohol dependence. Previous studies showed that disulfiram has antibiotic activity on multidrug-resistant bacteria. Here disulfiram was further evaluated for its ability to increase the potency of existing antimicrobials against the bacteria and yeast by acting as a drug adjuvant. Microbial cultures were treated with antibiotic or antifungal drugs in combination with disulfiram and its derivatives to determine whether potency is increased. The structure activity relationship (SAR) of disulfiram analogs was assessed against a triazole resistant Aspergillus panel. It showed that the shorter chained analogs of disulfiram are more potent against Aspergillus spp. In a separate study, this research examined whether disulfiram weakens bacteria to antibiotics. Bacterial cultures were re-exposed to disulfiram up to ten times then existing antibiotics were tested for potency. The increase in antibiotic potency gave evidence that disulfiram can lower the level of antibiotic resistance in bacteria. This is particularly evident with the decreased minimum inhibitory concentrations (MICs) for vancomycin (VAN) against the vancomycin-intermediate Staphylococcus aureus (VISA) and for ciprofloxacin and other fluoroquinolones against vancomycin-resistant enterococcus (VRE).","abstract_html":"Disulfiram (Antabuse) is an oral drug used for the treatment of alcohol dependence. Previous studies showed that disulfiram has antibiotic activity on multidrug-resistant bacteria. Here disulfiram was further evaluated for its ability to increase the potency of existing antimicrobials against the bacteria and yeast by acting as a drug adjuvant. Microbial cultures were treated with antibiotic or antifungal drugs in combination with disulfiram and its derivatives to determine whether potency is increased. The structure activity relationship (SAR) of disulfiram analogs was assessed against a triazole resistant Aspergillus panel. It showed that the shorter chained analogs of disulfiram are more potent against Aspergillus spp. In a separate study, this research examined whether disulfiram weakens bacteria to antibiotics. Bacterial cultures were re-exposed to disulfiram up to ten times then existing antibiotics were tested for potency. The increase in antibiotic potency gave evidence that disulfiram can lower the level of antibiotic resistance in bacteria. This is particularly evident with the decreased minimum inhibitory concentrations (MICs) for vancomycin (VAN) against the vancomycin-intermediate Staphylococcus aureus (VISA) and for ciprofloxacin and other fluoroquinolones against vancomycin-resistant enterococcus (VRE).","abstract_has_math":false,"creators":["Karuturi, Surya Bhaskar"],"institution":null,"degree_name":"Pharmaceutical Sciences","degree_level":"Thesis","degree_discipline":"School of Pharmacy","degree_department":null,"school":null,"contributors":["Dr. Timothy E Long","Dr. Michael Hambuchen","Dr. Hasan Koc"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-21T19:58:17Z","subjects":["Medicinal and Pharmaceutical Chemistry","Medicine and Health Sciences","Pharmaceutics and Drug Design","Pharmacy and Pharmaceutical Sciences","disulfiram","antimicrobials","adjuvant","antimicrobial resistance","antibacterial","antifungal"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://mds.marshall.edu/etd/1997","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://mds.marshall.edu/etd/1997","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://mds.marshall.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Amds.marshall.edu%3Aetd-3002","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Dr. Timothy E Long","Dr. Michael Hambuchen","Dr. Hasan Koc"]},{"key":"dc:creator","label":"Author","values":["Karuturi, Surya Bhaskar"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2025-11-17T08:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2025-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["School of Pharmacy"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Pharmaceutical Sciences"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Medicinal and Pharmaceutical Chemistry","Medicine and Health Sciences","Pharmaceutics and Drug Design","Pharmacy and Pharmaceutical Sciences","disulfiram","antimicrobials","adjuvant","antimicrobial resistance","antibacterial","antifungal"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://mds.marshall.edu/etd/1997"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Disulfiram (Antabuse) is an oral drug used for the treatment of alcohol dependence. Previous studies showed that disulfiram has antibiotic activity on multidrug-resistant bacteria. Here disulfiram was further evaluated for its ability to increase the potency of existing antimicrobials against the bacteria and yeast by acting as a drug adjuvant. Microbial cultures were treated with antibiotic or antifungal drugs in combination with disulfiram and its derivatives to determine whether potency is increased. The structure activity relationship (SAR) of disulfiram analogs was assessed against a triazole resistant Aspergillus panel. It showed that the shorter chained analogs of disulfiram are more potent against Aspergillus spp. In a separate study, this research examined whether disulfiram weakens bacteria to antibiotics. Bacterial cultures were re-exposed to disulfiram up to ten times then existing antibiotics were tested for potency. The increase in antibiotic potency gave evidence that disulfiram can lower the level of antibiotic resistance in bacteria. This is particularly evident with the decreased minimum inhibitory concentrations (MICs) for vancomycin (VAN) against the vancomycin-intermediate Staphylococcus aureus (VISA) and for ciprofloxacin and other fluoroquinolones against vancomycin-resistant enterococcus (VRE)."]},{"key":"dc:title","label":"Title","values":["Evaluation of disulfiram and derivatives as antimicrobial adjuvants"]}]}],"canonical_facts":{"dc:contributor":["Dr. Timothy E Long","Dr. Michael Hambuchen","Dr. Hasan Koc"],"dc:creator":["Karuturi, Surya Bhaskar"],"dc:date.available":["2025-11-17T08:00:00Z"],"dc:date.created":["2025-01-01T08:00:00Z"],"dc:description.abstract":["Disulfiram (Antabuse) is an oral drug used for the treatment of alcohol dependence. Previous studies showed that disulfiram has antibiotic activity on multidrug-resistant bacteria. Here disulfiram was further evaluated for its ability to increase the potency of existing antimicrobials against the bacteria and yeast by acting as a drug adjuvant. Microbial cultures were treated with antibiotic or antifungal drugs in combination with disulfiram and its derivatives to determine whether potency is increased. The structure activity relationship (SAR) of disulfiram analogs was assessed against a triazole resistant Aspergillus panel. It showed that the shorter chained analogs of disulfiram are more potent against Aspergillus spp. In a separate study, this research examined whether disulfiram weakens bacteria to antibiotics. Bacterial cultures were re-exposed to disulfiram up to ten times then existing antibiotics were tested for potency. The increase in antibiotic potency gave evidence that disulfiram can lower the level of antibiotic resistance in bacteria. This is particularly evident with the decreased minimum inhibitory concentrations (MICs) for vancomycin (VAN) against the vancomycin-intermediate Staphylococcus aureus (VISA) and for ciprofloxacin and other fluoroquinolones against vancomycin-resistant enterococcus (VRE)."],"dc:identifier":["https://mds.marshall.edu/etd/1997"],"dc:subject":["Medicinal and Pharmaceutical Chemistry","Medicine and Health Sciences","Pharmaceutics and Drug Design","Pharmacy and Pharmaceutical Sciences","disulfiram","antimicrobials","adjuvant","antimicrobial resistance","antibacterial","antifungal"],"dc:title":["Evaluation of disulfiram and derivatives as antimicrobial adjuvants"],"thesis:degree_discipline":["School of Pharmacy"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["Pharmaceutical Sciences"]},"updated_at":"2026-11-21T19:58:17Z"}